Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Raj K, Razdan"'
Autor:
John W. Huffman, Raj K. Razdan, Deryck K. Hill, Vanita Puri, Christopher S. Breivogel, Jonathan M. Lambert
Publikováno v:
Journal of Receptors and Signal Transduction. 33:367-379
Beta-arrestins are known to couple to some G-protein-coupled receptors (GPCRs) to regulate receptor internalization, G-protein coupling and signal transduction, but have not been investigated for most receptors, and for very few receptors in vivo. Pr
Publikováno v:
Drug and Alcohol Dependence. 105:42-47
Considerable preclinical research has demonstrated the efficacy of Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the primary psychoactive constituent of Cannabis sativa, in a wide variety of animal models of pain, but few studies have examined other
Publikováno v:
Neuroscience. 152:753-760
Cannabinoid receptor activation has been shown to modulate both neurotransmission (CB(1)) and neuroinflammatory (CB(2)) responses. There are conflicting reports in the literature describing the influence of cannabinoid receptor activation on ischemic
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:1504-1507
Fluorine’s high electronegativity and small size are among the special properties that contribute to its importance in medicinal chemistry.1 The effects of fluorine substitution on the biological behaviour of biologically active molecules have been
Autor:
Aron H. Lichtman, S. A. Varvel, Lesley A. Stevenson, Billy R. Martin, Adèle Thomas, Raj K. Razdan, Roger G. Pertwee, Ruth A. Ross
Publikováno v:
British Journal of Pharmacology. 150:586-594
Background and purpose: To follow up in vitro evidence that Δ9-tetrahydrocannabivarin extracted from cannabis (eΔ9-THCV) is a CB1 receptor antagonist by establishing whether synthetic Δ9-tetrahydrocannabivarin (O-4394) and Δ8-tetrahydrocannabivar
Autor:
Roger G. Pertwee, Ruth A. Ross, A. M. Phillips, Raj K. Razdan, Gemma L. Baillie, Adèle Thomas
Publikováno v:
British Journal of Pharmacology. 150:613-623
Background and purpose: A nonpsychoactive constituent of the cannabis plant, cannabidiol has been demonstrated to have low affinity for both cannabinoid CB1 and CB2 receptors. We have shown previously that cannabidiol can enhance electrically evoked
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 27:1387-1396
Cannabinoid CB2Receptor (CB2) activation has been shown to have immunomodulatory properties without psychotropic effects. The hypothesis of this study is that selective CB2agonist treatment can attenuate cerebral ischemia/reperfusion injury. Selectiv
Publikováno v:
Life Sciences. 80:24-35
The pharmacological profiles of the endocannabinoid anandamide and exogenous cannabinoids (e.g., Delta9-tetrahydrocannabinol) are similar, but not exactly the same. One notable difference is that anandamide's in vivo effects in mice are not blocked b
Autor:
Julia Adams, Irina Beletskaya, Billy R. Martin, William L. Dewey, Jenny L. Wiley, Laura J. Sim-Selley, Anu Mahadevan, Jean E. Cottney, Raj K. Razdan, Forrest L. Smith, James Baker, Bijali Saha, David E. Hill, John Zerkowski
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 318:1230-1239
Presently, there are numerous structural classes of cannabinoid receptor agonists, all of which require solubilization for experimental purposes. One strategy for solubilizing water-insoluble tetrahydrocannabinols is conversion of the phenolic hydrox
Autor:
Alessia Ligresti, David Baker, Jenny L. Wiley, Raj K. Razdan, Gareth Pryce, Maria Grazia Cascio, Cristina Visintin, Luciano De Petrocellis, Sanjitha Kulasegram, Irina Beletskaya, Bijali Saha, Billy R. Martin, Vincenzo Di Marzo, Anu Mahadevan
Publikováno v:
British journal of pharmacology 147 (2006): 83–91. doi:10.1038/sj.bjp.0706418
info:cnr-pdr/source/autori:Ligresti A; Cascio MG; Pryce G; Kulasegram S; Beletskaya I; De Petrocellis L; SahaB; Mahadevan A; Visentin C; Wiley JL; Baker D; Martin BR; Razdan RK; Di Marzo V/titolo:New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis/doi:10.1038%2Fsj.bjp.0706418/rivista:British journal of pharmacology/anno:2006/pagina_da:83/pagina_a:91/intervallo_pagine:83–91/volume:147
info:cnr-pdr/source/autori:Ligresti A; Cascio MG; Pryce G; Kulasegram S; Beletskaya I; De Petrocellis L; SahaB; Mahadevan A; Visentin C; Wiley JL; Baker D; Martin BR; Razdan RK; Di Marzo V/titolo:New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis/doi:10.1038%2Fsj.bjp.0706418/rivista:British journal of pharmacology/anno:2006/pagina_da:83/pagina_a:91/intervallo_pagine:83–91/volume:147
We previously reported that the compound O-2093 is a selective inhibitor of the reuptake of the endocannabinoid anandamide (AEA). We have now re-examined the activity of O-2093 in vivo and synthesized four structural analogs (O-2247, O-2248, O-3246,